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Abstract 
Polyglutamine expansions in the huntingtin gene cause Huntington's disease (HD). 
Huntingtin is ubiquitously expressed, leading to pathological alterations also in peripheral 
organs. Variations in the length of the polyglutamine tract explain up to 70% of the age-at-
onset variance, with the rest of the variance attributed to genetic and environmental 
modifiers. To identify novel disease modifiers, we performed an unbiased mutagenesis screen 
on an HD mouse model, identifying a mutation in the skeletal muscle voltage-gated sodium 
channel (Scn4a, termed ‘draggen’ mutation) as a novel disease enhancer. Double mutant mice 
(HD;Scn4a
Dgn/+
) had decreased survival, weight loss and muscle atrophy. Expression patterns 
show that the main tissue affected is skeletal muscle. Intriguingly, muscles from 
HD;Scn4a
Dgn/+
 mice showed adaptive changes similar to those found in endurance exercise, 
including AMPK activation, fibre type switching and upregulation of mitochondrial 
biogenesis. Therefore, we evaluated the effects of endurance training on HD mice. Crucially, 
this training regime also led to detrimental effects on HD mice. Overall, these results reveal a 
novel role for skeletal muscle in modulating systemic HD pathogenesis, suggesting that some 
forms of physical exercise could be deleterious in neurodegeneration. 
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Introduction 
Huntington´s disease (HD) is an autosomal dominant neurodegenerative disorder 
caused by pathogenic poly-glutamine expansions in the huntingtin gene (HTT) (1). 
Overlapping pathological mechanisms operate in HD pathogenesis, such as altered calcium 
metabolism, transcriptional impairment, altered autophagy or mitochondrial dysfunction, 
amongst others. Huntingtin is ubiquitously expressed (2). Consequently, although primarily a 
neurodegenerative disorder, HD also causes pathological changes in many peripheral tissues 
and organs including skeletal muscle (3, 4). Metabolic abnormalities in HD patients and 
mouse models are well established, particularly a hypermetabolic state accompanied by 
weight loss despite normal food intake, although their causes are not entirely clear (5, 6).  
Together with the brain, skeletal muscle is the main consumer of glucose, especially 
during exercise. Thus, changes in skeletal muscle homeostasis, including those induced by 
physical exercise or by pathological abnormalities, can in turn affect whole body metabolism, 
ultimately affecting the brain. In this sense, physical exercise has been tested as a possible 
treatment for HD (7). A recent clinical trial showed that moderate exercise was not 
detrimental to motor functions in HD patients (8). Studies in different HD mouse models 
have shown potential beneficial effects of moderate exercise, especially observed in 
hippocampal neurogenesis (9, 10). However, there are also several reports evidencing 
detrimental effects of exercise regimes in HD mice, as well as inconclusive studies in HD 
patients (11).  
 To date, many HD modifier genes have been described (12), offering potential novel 
therapeutic targets for further study. Here, we conducted a screen to search for novel HD 
modifier genes using the mouse as a complex model system. We identified the skeletal 
muscle voltage-gated sodium channel (Scn4a) as a novel modifier gene exacerbating the 
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overall HD disease phenotype. The interaction of Scn4a and HD mutations leads to higher 
energy demands that trigger adaptation changes in skeletal muscles. These adaptations are 
also observed after endurance training regimes, allowing us to show that physical exercise 
regimes leading to higher energy demands are detrimental in HD mice.  
 
 
Results  
A genetic screen in mice identifies the skeletal muscle sodium-gated voltage 
channel (Nav1.4, Scn4a) as a Huntington’s disease modifier gene 
We conducted an unbiased forward dominant genetic screen in mice that enables the 
identification of novel genes involved in the systemic alterations that occur through disease 
progression at the whole organismal level. Briefly, BALB/cAnN males were mutagenized 
with N-ethyl-N-nitrosourea (ENU), causing germline-transmitted random point mutations that 
were crossed to congenic C57BL/6J HD transgenic females (N171-82Q) generating mutant 
F1 HD mice that were then subjected to phenotypic screening (Supplementary Fig 1A). After 
identifying individual HD phenodeviants through behavioural phenotyping, we backcrossed 
them onto C57BL/6J to assess their progeny for inheritance of the selected modifier effects. 
From the modifier screen, we assessed around 350 HD F1 mice, of which 7% were selected 
as potential individual phenodeviants. Of the lines subjected to inheritance testing, 4 showed 
confirmed inheritance. Here we focus on one of the enhancer lines, that we called draggen, 
carrying a mutation in the Scn4a gene. Interestingly, as well as enhancing the overall HD 
phenotype, the mutation caused a new trait, intermittent paralytic attacks, appearing also 
independently of the HD transgene. In previous work, we segregated the draggen mutation 
from the HD transgene, cloned it and characterized it as a model of SCN4A channelopathies, 
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leading to non-dystrophic myotonia and intermittent attacks of hind-limb immobility 
followed by total recovery (13). Here we focus on the effects of Scn4a mutations as HD 
modifiers. In HD;Scn4a
Dgn/+
 mice, the draggen mutation exacerbated the overall HD 
phenotype, including accelerating the age at onset of tremors in HD males as well as 
dramatically reducing survival (defined as the age at which a set of humane endpoints are 
reached) (Fig 1, A and B). Sexual dimorphism was observed in the HD modifier effect 
(Supplementary Fig 1B). Due to the incomplete penetrance in females, we focused on males 
for the rest of the study. To confirm that Scn4a mutations can indeed modify the HD 
phenotype, we crossed HD transgenic mice to an independently generated Scn4a allele 
(Scn4a
M1592V/+
) (14). HD mice carrying the Scn4a M1592V mutation (HD; Scn4a
M1592V/+
) 
enhanced HD even more severely than the draggen mutation in both males and females (Fig 
1C and Supplementary Fig 1C). Thus, Scn4a mutations modify the overall HD phenotype in 
mice. 
As expected, Scn4a mRNA levels measured via qPCR are primarily expressed in 
skeletal muscle with marginal expression in the heart and practically no expression in brain; 
This expression pattern is not altered by the draggen mutation (Supplementary Fig 2A). We 
confirmed these results by analysing B-galactosidase staining on a Scn4a null allele carrying 
a LacZ reporter (Supplementary Fig 2B). Moreover, the mutant huntingtin transgene in 
N171-82Q mice is expressed in skeletal muscle at about half of the expression levels seen in 
brain (Supplementary Fig 2C). Thus, skeletal muscle is the only tissue showing high levels of 
expression for both genes. Due to the unique expression pattern of Scn4a, the study of its HD 
modifier effect allowed us to identify changes specifically in skeletal muscle that could be 
detrimental for systemic HD pathogenesis. To evaluate if the genetic interaction between the 
mutated forms of huntingtin and Scn4a could enhance HD pathology in the brain, we 
measured soluble mutant huntingtin and huntingtin intranuclear inclusions at piriform cortex 
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and cerebellum (Supplementary Fig 2, D and E), finding no differences between genotypes. 
In contrast, soluble mutant huntingtin levels were increased in HD;Scn4a
Dgn/+ 
skeletal 
muscles when compared to HD;Scn4a
+/+
 littermates (Fig 1D). 
One of the most important features observed in HD patients and mouse models is 
severe weight loss, which is partially explained by a hypermetabolic state (15) and 
progressive skeletal muscle atrophy. We evaluated whether accelerated muscle wasting and 
cachexia could be a possible cause of the early death observed in HD;Scn4a
Dgn/+ 
mice. We 
observed that HD;Scn4a
Dgn/+
male mice suffered from further progressive weight loss when 
compared to draggen or HD males alone 
 
(Fig 1E). This is reflected in a tendency towards 
increasing in vivo whole body energy expenditure of HD;Scn4a
Dgn/+ 
when compared to 
HD;Scn4a
+/+
 littermates at 8 weeks of age, with no major changes in food intake at this age 
(Supplementary Fig 3A). The weight differences between HD;Scn4a
+/+
 and  HD;Scn4a
Dgn/+ 
males were mainly explained by a reduction in fat mass progressively until disease end-stage 
(Fig 1F). Interestingly, at disease end-stage for double mutants (12 weeks of age), there is 
further loss of lean mass. At this end-stage, in double mutant mice, energy expenditure is still 
high compared to control wild-type mice (although similar to control HD;Scn4a
+/+
 mice), 
also showing a tendency towards a lower food consumption (Supplementary Fig 3B). This 
decrease in fat mass in HD;Scn4a
Dgn/+
 is consistent with changes in adiponectin levels and 
reduction of free fatty acid levels in plasma of HD;Scn4a
Dgn/+
 male mice (Fig 1G).  
All these data together suggest that the genetic interaction between Scn4a and HD 
mutations further increases the already elevated energy turnover of HD mice, potentially 
depleting the body of different energy sources that may accelerate the disease in double 
mutant mice. 
Scn4a mutations lead to mitochondrial enlargement and metabolic 
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy077/4917553
by guest
on 19 March 2018
 8 
 
adaptations in HD skeletal muscle 
We have previously observed that draggen mice when not in the context of the HD 
transgene (WT; Scn4a
Dgn/+
) have increased muscle activity (myotonia and intermittent 
paralytic attacks) which activated adaptive non-dystrophic changes, switching skeletal muscle 
fibres towards more oxidative types (13). These changes are physiological in a plastic tissue 
like skeletal muscle, but could be detrimental in a disease context. Thus, we first examined if 
these adaptive responses were also present in HD;Scn4a
Dgn/+
 mice, as they could be 
contributing towards the accelerated cachexic state in double mutants. First, we focussed on 
AMPK activation, the master energy sensor that is activated via phosphorylation when there 
is a deficit in energy supply. Interestingly, AMPK is activated to similar levels in skeletal 
muscle of HD;Scn4a
Dgn/+
 and WT;Scn4a
Dgn/+
mice, an activation likely driven by the draggen 
mutation alone (Fig 2A). Despite similar AMPK activation levels in skeletal muscle between 
WT controls (WT;Scn4a
+/+
) and HD transgenic mice (HD;Scn4a
+/+
), the levels of the 
AMPK-controlled glucose transporter GLUT-4 were downregulated in skeletal muscle in HD 
mice when compared to non-transgenic controls (Fig 2B), providing a potential explanation 
for the higher free-fed glucose levels in serum of HD mice (Fig 2C). Interestingly, the 
increase in AMPK activation in HD;Scn4a
Dgn/+ 
mice leads to a normalization of GLUT-4 in 
skeletal muscle to levels similar to WT mice (WT;Scn4a
+/+
), but still higher than HD controls 
(HD;Scn4a
+/+
). As a consequence, glucose levels are significantly reduced in HD;Scn4a
Dgn/+
 
when compared to any other genotype (Fig 2C). We validated these results by a glucose 
tolerance test (Supplementary Fig 3C), showing that HD;Scn4a
Dgn/+ 
are more efficient in their 
glucose uptake than HD controls. Overall, these results provide a potential mechanistic 
explanation for the reduced glucose levels observed in HD;Scn4a
Dgn/+ 
mice.  
Another adaptive consequence of the activation of AMPK in response to energy 
deprivation is the triggering of a mitochondrial biogenesis programme, leading to a shift of 
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muscle fibres towards more oxidative types (16). Indeed, we found an almost complete 
muscle fibre switching towards more oxidative types within the tibialis anterior (TA) muscle 
of draggen mice (in WT;Scn4a
Dgn/+
 mice and to a greater extent in HD;Scn4a
Dgn/+
) (Fig 2C 
and Supplementary Fig 4, A and B). At the electron microscopy level, enlarged mitochondria 
appeared in skeletal muscle from HD;Scn4a
Dgn/+
 mice at 12 weeks of age (Fig 2, D and E). 
This increased mitochondrial mass in HD;Scn4a
Dgn/+
 mice was confirmed by mitochondrial 
DNA analysis and by increased levels of mitochondrial components of the OXPHOS 
respiratory chain subunits (Supplementary Fig 4, C and D). It has been previously shown that 
mutant huntingtin interferes and disrupts the normal functioning of mitochondria at several 
levels (17-19). To determine whether those enlarged mitochondria were functional, we 
measured respiration from the dissociated muscle fibres from mice ex vivo. There was an 
increase in the overall Oxygen Consumption Rate (OCR), including a significant increase in 
the maximal uncoupled respiration rate of HD;Scn4a
Dgn/+ 
compared to HD;Scn4a
+/+ 
muscle 
bundles (Fig 2F), which as a consequence is associated with an increased production of 
reactive oxygen species (ROS).  
Overall, all these observations suggest that HD skeletal muscle is still capable of 
adapting to higher energy demands (such as the one posed by the increased activity due to 
Scn4a mutations), activating AMPK, enhancing mitochondrial function and increasing 
different fuel consumptions. Despite these adaptations, there is a dramatic acceleration of 
disease in HD;Scn4a
Dgn/+ 
mice, suggesting a detrimental effect for HD pathogenesis.  
Endurance exercise training is detrimental for HD in mice 
The effect of Scn4a mutations in skeletal muscle partially resembles the adaptations 
induced by endurance training exercise, leading to non-dystrophic changes mediated by 
constitutive AMPK activation (20, 21). It is very unlikely that a Huntington's patient would 
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also carry a SCN4A mutation. However, HD patients could carry other genetic variations 
affecting their energy balance and/or skeletal muscle activity, as well as variations 
modulating the response to environmental stimuli such as physical exercise. In this context, 
the effects of physical exercise in HD pathogenesis are still controversial, but are currently 
considered as a potential intervention that could be beneficial for HD (7) and other 
neurodegenerative disorders. However, according to our results, adaptations induced by 
increasing energy demands in skeletal muscle, including endurance exercise, might be 
detrimental for HD pathogenesis. Thus, to test this hypothesis, we established an endurance 
training routine for HD and WT littermate male mice, starting at 7 weeks of age and lasting 
for 6 weeks. First, we showed that the regime led to AMPK activation in skeletal muscle of 
HD mice (Fig 3A). We studied body composition before and after the endurance exercise 
regime, showing that exercised HD mice lose lean mass faster than sedentary HD controls by 
12 weeks of age (Fig 3B). Crucially, HD mice undergoing endurance training reached the 
humane endpoints significantly earlier than their sedentary HD littermates (Fig 3C). 
Remarkably, and concordantly with the findings in HD;Scn4a
Dgn/+
 muscles, enlarged 
mitochondria were also present in exercised HD mice, but not in their sedentary littermates at 
13 weeks of age (Fig 3D). Thus, at least in the mouse, endurance training leading to 
constitutive activation of AMPK in skeletal muscle is detrimental for HD pathogenesis.  
Discussion 
Through an unbiased genetic screen in mice we have identified Scn4a as a novel HD 
modifier. As Scn4a is primarily expressed in skeletal muscle, analysis of the modifier effect 
highlighted a novel critical role of the periphery in modulating systemic HD pathogenesis. 
The phenotypic modification occurs through a mechanism mediated by AMPK activation 
inducing skeletal muscle adaptations leading to high-energy demands. We propose that this 
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energetic imbalance produced by skeletal muscle adaptations ultimately exacerbates systemic 
HD progression. Thus, to test this hypothesis independently of Scn4a mutations, we subjected 
HD mice to an endurance training regime that phenocopies the adaptive changes present in 
skeletal muscle of HD;Scn4a
Dgn/+
 mice. As we anticipated, endurance exercise was 
detrimental for HD mice. Thus, the critical linking point between the two sets of experiments 
is that they both highlight a critical role for the periphery in modulating systemic HD 
pathogenesis. Overall, using two independent approaches in mice, we showed that skeletal 
muscle adaptations mediated by constitutive AMPK activation are detrimental for systemic 
HD pathogenesis.  
Mitochondrial impairment and energy balance dysregulation have been previously 
associated with HD pathogenesis (15, 22, 23). Thus, interventions aimed at increasing energy 
production or mitochondrial biogenesis either by genetic means, physical exercise or drugs, 
have been proposed and tested as potential treatments for HD and other neurodegenerative 
disorders. Moreover, a recent clinical trial showed that moderate exercise stabilized motor 
functions in HD patients, although bigger study sizes are needed to assess other effects (8). 
However, there are several reports evidencing detrimental effects of exercise regimes in HD 
mice (24) as well as inconclusive studies in HD patients (11). Furthermore, activation of 
AMPK by injection of the AMPK-activating drug AICAR increased neuronal death and 
decreased lifespan in HD mice (25). Our data here provides a potential explanation for the 
inconsistencies on the effects of physical exercise in HD pathogenesis, as some regimes but 
not others may lead to adaptive changes in skeletal muscle. In light of our data, the potential 
benefits of augmenting mitochondrial function in HD may be enhanced when accompanied 
by increasing fuel supply.  
Overall, our findings suggest caution to interventions aimed at HD patients that may 
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lead to higher energy demands, including stringent physical exercise or drugs aimed at 
increasing mitochondrial function.  
 
Materials and Methods 
Mice. Mice were kept under a controlled 12-hour light cycle and had free access to water and 
were fed ad libitum on a commercial diet (SDS). Draggen mice were identified through a 
dominant modifier ENU screen (26) injecting BALB/c male mice with ENU and crossing 
them with (N171-82Q) HD hemizygous carrier females on a C57BL/6J background. All G1 
mice produced were genotyped for the HD transgene and were subject to a behavioural 
screening pipeline including: general dysmorphology and SHIRPA analysis, weight and grip-
strength measurements. Identified individual G1 pheno-deviant mice that showed novel 
phenotypes or modulate the HD disease onset of progression of the parental N171-82Q HD 
line on a C57BL/6J-BALB/c hybrid background were selected for further analysis and 
backcrossed onto C57BL/6J to assess inheritance. After inheritance was established, a 
positional cloning approach was followed using a panel of single nucleotide polymorphisms 
(SNPs) polymorphic between the two parental strains. 
The draggen mutation was first identified in the context of the HD transgene through the 
ENU modifier screen. After backcrossing to C57BL/6J, the draggen mutation was segregated 
from the HD transgene. The cloning of the draggen mutation and the characterization of the 
draggen mice when not in the context of the HD mutation has already been published, using 
the characteristic intermittent attacks of hind-limb immobility as the initial phenotypic 
selected trait. The draggen official allele name is: Scn4a
m1Aaa
. Mice homozygous for the 
draggen mutation are not viable, therefore all the work performed here is on heterozygous 
draggen carriers. 
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Draggen mice used here are at least N3 (three generations of backcross onto C57BL/6J); the 
colony is currently backcrossed for more than ten generations onto C57BL/6J (>N10). All 
mice produced for this study were obtained by intercrossing both mutations in heterozygosis, 
producing all four possible genotypes from the same cross (WT;Scn4a
+/+
, WT;Scn4a
Dgn/+
, 
HD;Scn4a
+/+
 and HD;Scn4a
Dgn/+
), allowing to use littermate controls. Experiments were 
performed blind to genotype and lifespan was defined by mice reaching one of the following 
humane end-points: loss of 20% of maximum body weight, the presence of hunched posture 
and piloerection or the appearance of hind-limb paralytic attacks lasting longer than one 
minute with no full recovery.  
Scn4a
M1592V/+
 (FVB.129S4(B6)-Scn4a
tm1.1Ljh
/J) mice were purchased from Jackson 
laboratories (USA) on a congenic FVB background and generated the four desired genotypes 
by crossing WT;Scn4a
M1592V/+
 to HD;Scn4a
+/+
 mice. Scn4a
M1592V/+
 mice were maintained in a 
hybrid C57BL/6J-FVB background. All genotyping was performed by pyrosequencing or 
light scanner (For primer list used, see Supplementary Table 1). 
Scn4a deficient mice (Scn4a
tm2b(KOMP)Wtsi
) were produced at MRC Harwell through the IMPC 
programme and are distributed through the European Mouse Mutant Archive 
(www.infrafrontier.eu). Cre expression deleted the critical exon, producing a lacZ tagged null 
allele.  
Phenotyping tests.  
The number of animals was chosen based on previous studies. For in vivo behavioural tests 
we required a minimum of 7 mice per sex and genotype.  Modified SHIRPA methods were 
performed as described previously (27, 28). Tremors were qualitatively assessed by 
observation in a viewing jar and recorded as having no tremors (0), mild tremors (1), 
moderate tremors (2) or severe tremors (3). Mice were subject to modified SHIRPA analysis 
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from 7 weeks of age until they reached their humane endpoint. Paralytic attacks were 
evaluated weekly as previously described (13). 
Metabolic rate was measured at 8 and 12 weeks of age, with measurements performed for 22 
h during the light and dark period, using indirect calorimetry TSE systems to determine 
Energy Expenditure (E.E). Fat and lean mass in the body were determined by EchoMRI 
(EchoMRI-100™) scan system. For intraperitoneal glucose tolerance test (IPGTT), mice 
were fasted overnight (16 h) to establish a baseline glucose level 'T0' (time zero). A blood 
sample was collected from the tail vein after administration of local anesthetic. Mice were 
then injected intraperitoneally with 2 g of glucose per kg body weight (20% glucose in 0.9% 
NaCl). Blood samples were taken at 15 min, 30 min, 60 min and 120 min after injection and 
glucose was measured using Alphatrak2 glucose analyser (Abbott Laboratories, USA). 
Endurance exercise challenge. Wild type and HD N171-82Q male mice littermates on a 
congenic C57BL/6J background had thirty minutes of forced exercise in the rotarod at 
constant speed (15 rpm), five days a week, plus a running wheel in their home cages, 
allowing for additional voluntary exercise. The routine started from pre-symptomatic (around 
7 weeks of age) until they reached the humane end points in the case of HD mice (for 
survival analysis), or until 12 weeks of age for nonHD mice and for HD mice used for 
molecular analysis. Wild type and HD littermates were used for the sedentary group controls. 
Fat and lean mass in the body were determined by EchoMRI before (at the beginning of the 
experiment) and after 5 weeks of training. 
Blood parameters. Terminal blood samples were collected from mice aged 12 weeks (n=5-7 
per group). Mice were fasted 4 hours prior to blood collection. Blood samples were collected 
under terminal isofluorane inhalation anaesthesia by retro-orbital puncture into paediatric 
lithium heparin coated tubes. Lithium heparin samples were kept on wet ice until being 
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centrifuged for 10 minutes at 8000 x g at 4°C. The resulting plasma was analysed on board a 
Beckman Coulter AU680 clinical chemistry analyser using reagents and settings 
recommended by the manufacturer. Plasma mouse adiponectin was measured using an 
ELISA kit from Life Technology.  
Respiration analysis in muscles ex vivo. Respiration measurements were made from muscle 
bundles ex vivo using a high-resolution respirometry system Oxygraph-2k (Oroboros 
Instruments, Bioblast) which allows for the analysis of mitochondrial respiratory chain 
activity from mouse muscle fibers. We compared oxygen consumption rates (OCR) of 
extensor digitorum longus (EDL) muscle from male mice aged 12 weeks (HD;Scn4a
+/+
 n=6, 
and HD;Scn4a
Dgn/+ 
n=5). Briefly, dissected EDL muscles were placed in ice-cold BIOPS 
solution (10 mM Ca-EGTA buffer, 0.1 µM free calcium, 20 mM imidazole, 20 mM taurine, 
50 mM K-MES, 0.5 mM DTT, 6.56 mM MgCl2, 5.77 mM ATP, 15 mM phosphocreatine, 
pH 7.1) and were separated lengthways to obtain bundles of fibres. Three bundles per EDL 
were permeabilized with saponin for 30 min in ice-cold BIOPS, prior to washing and 
transferring to the mitochondrial medium for OCR measurements in the Oroboros chambers 
according to the manufacturer’s protocol. A specially designed substrate/inhibitor titration 
approach allowed the step-by-step analysis of the activity of the respiratory chain (RC) as a 
whole as well as the relative contribution to total activity of RC complexes I and II, the two 
entry points for electrons. Additions of substrates and inhibitors were in the following order 
and final concentration: Malate 2 mM, Glutamate 10 mM, ADP 2.5 mM, Cytochrome c 10 
µM, Succinate 10 mM, titrations of 0.25 µM with the protonophore uncoupler Carbonyl 
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) until maximal uncoupled respiration 
was reached, Rotenone 0.5 µM, and finally Antimycin A 2.5 µM. State 2 respiration was 
obtained following additions of Malate and Glutamate, State 3 after ADP, Maximal 
uncoupled after FCCP. The relative proportion of total respiratory chain activity dependant 
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on either of the two entry points of the RC (i.e. Complex I and II) were measured as the 
Rotenone sensitive component of Maximal Uncoupled respiration for complex I and the 
remaining activity as that for Complex II. After the experiment, muscle bundles were 
recovered, homogenized and total protein concentration was measured in order to correct the 
OCRs by the total amount of protein per chamber. For the acquisition and analysis of data the 
manufacturers DatLab software was used (Oroboros Instruments, Austria). 
Histology. Tibialis anterior (TA) from male mice for the four genotypes (n=3 per group) 
were dissected at 12 week of age, weighed and snap frozen and 10 µm sections were cut in a 
cryostat. TA sections were stained for NADH-tetrazolium reductase and ATPasa.  
To detect mutant human huntingtin intranuclear inclusions in the brain, we conducted the 
same protocol as previously described (29). Mice were transcardially perfused with 4% 
paraformaldehyde (PFA), brain removed and placed in PFA for another 4-6 hours. After 30% 
sucrose protection, brains were crypreserved at -80 degrees until used. Free-floating 
cryosections at 30 µm were immunostained against mutant huntingtin using mouse anti- 
human polyQ (MAB5374 Millipore, 1:500) overnight. The seconday antibody was Alexa 488 
(Life Technology) and nuclear DAPI counterstaining (Prolong, Life technology). Confocal 
images were taking using Zeiss LSM 700 microscope at 60X amplification of the granular 
layers in the cerebellum. Final images stack projections (typically the sum of 8 images per 
projection) were used to count the total of inclusions per field. A minimum of three fields per 
slice, over 3 or 4 slices were used to account for the total number of inclusions per mouse. 
Volocity software 5.4.1 (Perkin Elmer, USA) was used to analyse the total count and 
classified by the size of the inclusions per image. The given data is a relative proportion of 
each size group to the total, falling into four categories, from the smallest aggregates (0-2 
µm
2
) to the biggest inclusions found (more than 6 µm
2
). 
Transmission electron microscopy. Mice were perfused with a mix of 2% glutaraldehyde 
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and 2% paraformaldehyde in PBS. TA muscles were dissected and placed in 1% OsO4 on ice 
for 1 hour followed by two 5 minutes washes with Phosphate buffer (100mM 
NaH2PO4/Na2HPO4.2H20). The samples were dehydrated through an ethanol series (30%, 
50%, 70%, 95% and absolute) and transferred to a 1:1 mixture of Epon/Araldite and acetone 
and incubated overnight with mixing. The solution was then replaced with a 1:1 mixture of 
100% Epon/Araldite and incubated for 6 h, followed by another replacement with fresh 
Epon/Araldite and overnight incubation with mixing. Samples were transferred to fresh 
Epon/Araldite in embedding molds and oriented as required. Polymerization of the 
Epon/Araldite mold was completed at 65°C for 48 h. 70 nm sections were produced and 
stained with saturated uranyl acetate and Reynolds’ lead citrate. All images were obtained 
with a Tecnai 12 BioTWIN made by FEI, Eindhoven. Quantification of the TEM images was 
done by Image J software.  
Immuno-blot analysis. Snap frozen TA muscles and forebrain from male 12 week-old male 
mice were homogenized in RIPA buffer (150 mM NaCl, 1% NP40, 0.5% Na deoxycholate, 
0.1% SDS, 50 mM Tris pH 7.5) with phosphatase and protease inhibitor cocktails (Roche), 
using lysing matrix tubes D (MP Biomedicals, Germany) an`d a Fast-Prep-24 homogenizer at 
4°C. Homogenates were centrifuged at 12,000 g 4°C for 20 min. 40 µg of soluble fractions 
were resolved by SDS–PAGE (NUPAGE system, Invitrogen) and transferred to low 
fluorescent PVDF (PVDF-LF) membranes (Millipore) for western-blot analysis. The 
following primary antibodies were used: rabbit monoclonal anti-actin (A2066, Sigma, 
1:3000); mouse anti-α tubulin (ab7291, abcam, 1:3000), mouse anti-GAPDH (ab8245, 
abcam, 1:5000); mouse anti-soluble human polyQ (MAB1537-1C2, Millipore, 1:800), rabbit 
anti-p-AMPKα (Thr-172, 2535-40H9) and mouse anti-total AMPKα (2793, both Cell 
Signalling, 1:1000); rabbit anti-GLUT-4 (CBL243, Millipore). Total protein loading and 
transfer was also quantified using REVERT kit (Li-Cor Biosciences). Protein was visualized 
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using anti-mouse or anti-rabbit secondary antibodies IRDye
®
 (Li-Cor Biosciences) at 
1:10000 dilutions and quantified using the infrared Odyssey imaging system (Li-Cor 
Biosciences).  
Mitochondria DNA analysis. EDL (Extensor Digitorum Longus) fast muscles were used to 
quantify the amount of mitochondria DNA in all experimental groups by quantitative PCR 
(males, n=7 per group). DNA extraction was performed using DNA-blood and tissues kit 
(Qiagen) following manufacturer's instructions. The sequences of the primer used are detailed 
in Supplementary Table 1.  
Gene expression analysis. RNA extraction was performed using RNeasy kit (Qiagen) from 
whole brain and Quadriceps. The quantity of the RNA was checked using a nanodrop and the 
quality was assessed using Bioanalyser. RINs of over 7.5 were always observed. cDNA 
synthesis was performed using the High Capacity cDNA RT kit ( ThermoFisher Scientific) 
starting with 2µg of RNA. cDNA was at a final concentration of either 20 ng or 50 ng per 
well depending upon the gene being studied. All the reactions were run in triplicate. The real-
time experiments were performed on a 7900 fast machine (ThermoFisher Scientific). For the 
probe based experiments, TaqMan Fast Universal PCR Master was used and the reactions 
had a final volume of 20µl, and Taqman assays (ThermoFisher Scientific) used as per 
manufactures recommendations. For the sybr experiments; fast Sybr Green mastermix from 
ThermoFisher Scientific was used and the reactions had a final volume of 20µl. Primers were 
at a final concentration of 360nM. Primers were designed to span exon-exon boundaries and 
are listed in Supplementary Table 1. Fold changes were calculated using the 2-ddCt method 
using the 7500 Software v2.0.6 and normalized using S16 or S18 endogenous reference genes 
relative to HD;Scn4a
+/+
  genotype (30).  
Statistical analysis. Error bars represented SEM. P values of less than 0.05 were considered 
significant. P values comparing two HD groups were calculated using the two-tailed Student's 
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t-test (with Welch’s correction or Mann-Whitney when appropriate) and ANOVA with 
Tukey postHoc analysis. Log-Rank test was used for survival and age at onset analysis, and 
ANCOVA regression model for Energy Expenditure analysis.  
Study approval. All animal studies were carried out in accordance with UK Home Office 
legislation and local ethical guidelines. Mice characterization followed ARRIVE guidelines.  
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Figure legends 
Fig 1. Scn4a mutations exacerbate HD leading to further metabolic alterations. (A) 
Cumulative tremor onset events from 7 weeks of age (HD;Scn4a
+/+
 (n=20) average onset: 
10.1 weeks; HD;Scn4a
Dgn/+
 (n=31) average onset: 8.4 weeks. p<0.001). (B) Draggen 
mutation decrease survival on HD males (HD;Scn4a
+/+
 (n=28) average survival: 19.4 weeks; 
HD;Scn4a
Dgn/+
 (n=39) average survival: 14.3 weeks. p<0.001. (C) The M1592V Scn4a 
mutation decreases survival in HD male mice (HD;Scn4a
+/+
 (n=12) average survival: 15.8 
weeks; HD;Scn4a
M1592V/+
 (n=14) average survival: 7.7 weeks. p<0.001). (D) Representative 
immunoblot and analysis of levels of soluble mutant huntingtin from TA muscle corrected by 
GAPDH (n=5, p=0.0018). (E) Body weights from 5 weeks of age until disease end-point. At 
least 13 male mice per genotype and time-point, (p<0.05 from 5 weeks onwards comparing 
HD;Scn4a
Dgn/+
 to any other group). (F) Whole body fat and lean mass in male mice at 8 (n=5 
nonHD and n=8 HD groups) and 12 weeks of age (n=5 nonHD groups and n=10 HD groups). 
(G) Free-fed circulating levels of adiponectin and free-fatty acids in plasma of male mice at 
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12 weeks of age (n=5 nonHD and n=8 HD groups). WT= WT;Scn4a
+/+
, Dgn= 
WT;Scn4a
Dgn/+
, HD;WT= HD;Scn4a
+/+
 and HD;Dgn= HD;Scn4a
Dgn/+
. *P< 0.05, **P< 0.01, 
***P< 0.001.  
 
Fig 2. HD muscles carrying Scn4a mutation showed adaptive changes to higher energy 
demands. All analysis from male TA muscle at 12 weeks of age, unless stated otherwise. (A 
and B) Immunoblot of AMPKα activation levels measured via the ratio of Thr321 
phosphorylated AMPK versus total AMPKα (A), and glucose transporter (GLUT-4) protein 
levels corrected by tubulin (B), (n=3 nonHD; n=4 HD groups). (C) Free-fed circulating levels 
of glucose. (D) Representative images of whole muscle (first row) and sections. Second and 
third panel rows show comparable TA transversal sections stained with NADH-TR and 
Alkaline ATPasa activity, showing oxidative fibre grouping in HD;Scn4a
Dgn/+ 
(yellow arrow). 
(E) Representative TEM muscle micrographs. Arrows point to the appearance of enlarged 
mitochondria. Scale bar represents 2 µm. Quantification of the average mitochondria area and 
size in TEM. Each bar represents the average of n=3-5 mice per group and at least 5 
comparable TEM per mouse. (F) Analysis of mitochondrial respiration (Oxygen 
Consumption Rate (OCR)) ex vivo from permeabilized fibre bundles of EDL muscle using 
high resolution respirometry (n=5). Graph bars represent mean ± SEM and values are relative 
to the average HD; Scn4a
+/+
 group value. *P< 0.05, **P< 0.01, ***P< 0.001.  
 
Fig 3. Endurance exercise is detrimental for HD.  
(A) Immunoblots for AMPKα activation in TA muscles (n=4 in WT, n=6 in HD groups) after 
6 weeks of sedentary or exercise (B) Whole body fat and lean mass in male WT (n=5) and 
HD (n=7) mice before (around 7-8 weeks of age) and after 6 weeks sedentary or exercise 
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regime. (C) Graph showing decrease survival in HD mice with endurance exercise (n=7; 
p=0.003). (D) TEM images from TA muscles of HD mice in the sedentary and exercise 
group (yellow arrow pointed at mitochondria). Quantification of the average mitochondria 
total area in TEM. Each bar represents the average of n=2-4 mice per group in at least 3 
comparable micrographs per mouse including 40-60 mitochondria per micrograph. Graph 
bars represent mean ± SEM. Statistical evaluation between HD groups by 2-tailed t-Student 
with Welch’s correction. *P< 0.05, **P< 0.01. 
Abbreviations 
HD Huntington’s disease; Dgn Draggen.  
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